Picture of Vilin Bio Med logo

VILINBIO Vilin Bio Med Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-3.02%
3m-9.56%
6m-25.41%
1yrn/a
Volume Change (%)
10d/3m-57.79%
Price vs... (%)
52w High-37.6%
50d MA-3.76%
200d MA-14.55%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.05
Price to Tang. Book3.05
Price to Free Cashflow127.06
Price to Sales2.36
EV to EBITDA42.62

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.91%
Return on Equity0.42%
Operating Margin4.87%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202331st Mar 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Vilin Bio Med EPS forecast chart

Profile Summary

Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.

Directors

    Last Annual
    March 31st, 2022
    Last Interim
    December 31st, 2022
    Incorporated
    June 29th, 2005
    Public Since
    June 30th, 2023
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    in flag iconNational Stock Exchange of India
    Shares in Issue
    13,950,000

    VILINBIO Share Price Performance

    Similar to VILINBIO

    Picture of Aarey Drugs and Pharmaceuticals logo

    Aarey Drugs and Pharmaceuticals

    in flag iconNational Stock Exchange of India

    Picture of Aarti Drugs logo

    Aarti Drugs

    in flag iconNational Stock Exchange of India

    Picture of Aarti Pharmalabs logo

    Aarti Pharmalabs

    in flag iconNational Stock Exchange of India

    Picture of Abbott India logo

    Abbott India

    in flag iconNational Stock Exchange of India

    Picture of Accent Microcell logo

    Accent Microcell

    in flag iconNational Stock Exchange of India

    FAQ